Additionally, IFT20 interacts with the actin-associated protein Tagln2, which limits cell migration and whose expression is downregulated in IFT20-deficient breast cancer cells, which may further contribute to their enhanced migration [56]. This evidence concerns the gene IFT20 and breast carcinoma.